The negative impact of HBV/HCV coinfection on cirrhosis and its consequences
ContributorsPol, S; Haour, G; Fontaine, H; Dorival, C; Petrov-Sanchez, V; Bourliere, M; Capeau, J; Carrieri, P; Larrey, D; Larsen, C; Marcellin, P; Pawlostky, J-M; Nahon, P; Zoulim, F; Cacoub, P; de Ledinghen, V; Mathurin, P; Negro, Francesco; Pageaux, G-P; Yazdanpanah, Y; Wittkop, L; Zarski, J-P; Carrat, F
Published inAlimentary Pharmacology and Therapeutics, vol. 46, no. 11-12, p. 1054-1060
Publication date2017
Abstract
Keywords
- Adult
- Aged
- Cohort Studies
- Coinfection/virology
- Female
- Hepatitis B/epidemiology/pathology
- Hepatitis C/epidemiology/pathology
- Hepatitis C Antibodies
- Humans
- Liver Cirrhosis/epidemiology/pathology
- Male
- Middle Aged
Research groups
Citation (ISO format)
POL, S et al. The negative impact of HBV/HCV coinfection on cirrhosis and its consequences. In: Alimentary Pharmacology and Therapeutics, 2017, vol. 46, n° 11-12, p. 1054–1060. doi: 10.1111/apt.14352
Main files (1)
Article (Published version)
Identifiers
- PID : unige:106611
- DOI : 10.1111/apt.14352
- PMID : 28994127
ISSN of the journal0269-2813
